The American Medical Association (AMA) announced on March 26 new CPT coding and reporting guidance for physicians and medical practices, intended to simplify reporting of in-person and online visit services for novel coronavirus (COVID-19) patients.
CMS lifted some restrictions on telehealth coverage in a bid to keep non-critically ill patients out of clinics and hospitals to slow down the spread of the novel coronavirus (COVID-19), but other still apply to hospitals.
With the release of a new ICD-10-CM code for the novel coronavirus (COVID-19), hospitals now have a method to capture and report this critical disease. Although the code itself is relatively straightforward and likely won’t stir up confusion the way coding for complex diagnoses (such as sepsis) does, correctly documenting and coding COVID-19 is crucial to turning the tide on the national public health emergency.
Providers and payers now have revised tabular and index information for new ICD-10-CM code U07.1 (COVID-19) issued today by the panel that maintains the diagnosis code set in the U.S.
The COVID-19 pandemic has created new challenges for the healthcare industry and revenue integrity is no exception as departments work to tackle new billing and coding guidance.
CMS released an update to its FAQon coding and billing for the novel coronavirus (COVID-19) on March 23. The FAQ clarifies the use of HCPCS and CPT® codes for diagnostic laboratory services.
Q: As our organization provides telephone and telemedicine encounters for services, we are considering using Q3014 for our provider-based departments in addition to the professional E/M. Does anyone have any experience with this code? If provider-based, are you applying this to a UB and the professional E/M to a 1500?
CMS announced blanket waivers of certain Medicare requirements to prevent gaps in care for beneficiaries affected by the novel coronavirus (COVID-19) public health emergency. The agency released billing instructions and a set of Q&As.
